Aronex Pharma (ARNX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aronex Pharma (ARNX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: GTC Trader who wrote (183)	11/16/1998 4:06:00 PM
From: Sam Lee	Read Replies (1) of 320

Sell on news seems to be the order of the day. The news was good. My source thinks Aronex is now in good enough shape to get through another 12-18 months during which time the company will probably hit certain milestones that will add more money to the kitty. Patient acquisition re nyotran to be completed by the end of December and then NDA by May will get us more payments. Another conference call to be held soon for questions. The company will get more institutional sponsorship as time goes by now that they have this deal. My source says that this is a $12+ stock w/i 12 months or less. The sleeper is atragen. That could be really big according to a doctor friend who likes the prospects.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next